BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29117356)

  • 1. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
    Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
    Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
    J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma.
    Li M; Zhao BR; Liu SQ; An J; Deng PB; Han-Zhang H; Ye JY; Mao XR; Chuai SK; Hu CP
    Cancer Biol Ther; 2018; 19(10):898-903. PubMed ID: 30067437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression.
    Cordesmeyer R; Laskawi R; Schliephake H; Kauffmann P; Beck J; Bornemann-Kolatzki K; Schütz E; Ströbel P; Kueffer S; Fichtner A; Bremmer F
    Oral Oncol; 2020 Apr; 103():104615. PubMed ID: 32120340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
    Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing of adenoid cystic carcinoma.
    Stephens PJ; Davies HR; Mitani Y; Van Loo P; Shlien A; Tarpey PS; Papaemmanuil E; Cheverton A; Bignell GR; Butler AP; Gamble J; Gamble S; Hardy C; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; McLaren S; McBride DJ; Menzies A; Mudie L; Maddison M; Raine K; Nik-Zainal S; O'Meara S; Teague JW; Varela I; Wedge DC; Whitmore I; Lippman SM; McDermott U; Stratton MR; Campbell PJ; El-Naggar AK; Futreal PA
    J Clin Invest; 2013 Jul; 123(7):2965-8. PubMed ID: 23778141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.
    Papadaki H; Finkelstein SD; Kounelis S; Bakker A; Swalsky PA; Kapadia SB
    Hum Pathol; 1996 Jun; 27(6):567-72. PubMed ID: 8666366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
    J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma.
    Wang R; Geng N; Zhou Y; Zhang D; Li L; Li J; Ji N; Zhou M; Chen Y; Chen Q
    Biomed Mater Eng; 2015; 26 Suppl 1():S2145-53. PubMed ID: 26405993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.
    Ling S; Rettig EM; Tan M; Chang X; Wang Z; Brait M; Bishop JA; Fertig EJ; Considine M; Wick MJ; Ha PK
    Int J Oncol; 2016 Jul; 49(1):225-34. PubMed ID: 27212063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.
    Hanna GJ; Grover P; Elliott A; McGrath J; Xiu J; Sukari A; Johnson JM; Wise-Draper T
    Clin Cancer Res; 2024 May; 30(10):2225-2232. PubMed ID: 38416410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands.
    Tetsu O; Phuchareon J; Chou A; Cox DP; Eisele DW; Jordan RC
    Neoplasia; 2010 Sep; 12(9):708-17. PubMed ID: 20824047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.
    Ferrarotto R; Mitani Y; McGrail DJ; Li K; Karpinets TV; Bell D; Frank SJ; Song X; Kupferman ME; Liu B; Lee JJ; Glisson BS; Zhang J; Aster JC; Lin SY; Futreal PA; Heymach JV; El-Naggar AK
    Clin Cancer Res; 2021 Feb; 27(3):852-864. PubMed ID: 33172898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Ezrin gene on the proliferation and invasion activity of human salivary gland adenoid cystic carcinoma].
    Wang YY; Chen WL; Yang ZH; Huang ZQ; Li JS; Pan CB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):203-7. PubMed ID: 19575999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays.
    Yu Y; Baras AS; Shirasuna K; Frierson HF; Moskaluk CA
    Lab Invest; 2007 May; 87(5):430-9. PubMed ID: 17372589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma.
    Ding LC; She L; Zheng DL; Huang QL; Wang JF; Zheng FF; Lu YG
    Oncol Rep; 2010 Aug; 24(2):363-8. PubMed ID: 20596622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.